NIH-funded research NIH-funded research

Center for Precision Theranostics at MSK Monmouth

Official title: BRF: MSK Center for Precision Theranostics – Monmouth, NJ

Funded at Sloan-Kettering Inst Can Research · NIH-11523119 · Data updated 2026-11-12

A new center at MSK Monmouth will combine cancer imaging and therapy in one program to speed up the development and testing of targeted cancer treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 18, 2026
Project endSeptember 30, 2028
Funding year2026
Award (this year)$7,892,852
NIH project number1C06OD042699-01
Project IDNIH-11523119 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cancer who may benefit from theranostic approaches and participate in translational imaging and early clinical development efforts.

Less likely to help

Patients not matched to theranostic targets or not enrolled in related early-stage studies may not benefit.

What this research studies

This project creates a dedicated facility to house imaging, radiopharmacy, and treatment suites that enable simultaneous diagnostic and therapeutic work in cancer. Researchers across MSK and partner institutions will use the center to move theranostic candidates from early development toward patient-ready indications. The center will include PET/CT and SPECT/CT imaging, a radiopharmacy, radiation safety systems, and streamlined workflows to support safe, rapid testing in trials and translational studies. By reducing bottlenecks in imaging, dosimetry, and therapy delivery, the center aims to accelerate precision cancer treatments for patients. </= 4 sentences

Why it matters

Potential benefit: If successful, the center could shorten the path from discovery to effective personalized cancer therapies.

How similar studies have gone: Current centers have shown that integrated theranostics facilities can accelerate translational progress and patient access to targeted therapies.

Where this research is happening

  • Sloan-Kettering Inst Can Research
    New York, United States
    Active

Researchers

  • Principal investigator: Vickers, Selwyn M — Sloan-Kettering Inst Can Research
  • Study coordinator: Vickers, Selwyn M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.